Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections
Fig 9
Validation of hub genes and candidate drugs in favor of SARS-CoV-2 by the literature review.
(A) Validation of the proposed HubGs: circles with node color indicates hub genes, and each connected network with number(s) indicates the reference(s) of gene(s) of SARS-CoV-2 (B) Validation of the proposed candidate drugs: circles with green color indicate FDA approved, light blue color indicates investigational drugs and purple color indicates experimental drugs and red color indicates unapproved drugs, and each connected network with number(s) indicates the reference(s) of drug(s) of SARS-CoV-2.